Dietary fat types and 4-year cognitive change in community-dwelling older women
- PMID: 22605573
- PMCID: PMC3405188
- DOI: 10.1002/ana.23593
Dietary fat types and 4-year cognitive change in community-dwelling older women
Erratum in
- Ann Neurol. 2012 Oct;72(4):627
Abstract
Objective: A study was undertaken to relate dietary fat types to cognitive change in healthy community-based elders.
Methods: Among 6,183 older participants in the Women's Health Study, we related intake of major fatty acids (saturated [SFA], monounsaturated [MUFA], total polyunsaturated [PUFA], trans-unsaturated) to late-life cognitive trajectory. Serial cognitive testing, conducted over 4 years, began 5 years after dietary assessment. Primary outcomes were global cognition (averaging tests of general cognition, verbal memory, and semantic fluency) and verbal memory (averaging tests of recall). We used analyses of response profiles and logistic regression to estimate multivariate-adjusted differences in cognitive trajectory and risk of worst cognitive change (worst 10%) by fat intake.
Results: Higher SFA intake was associated with worse global cognitive (p for linear trend = 0.008) and verbal memory (p for linear trend = 0.01) trajectories. There was a higher risk of worst cognitive change, comparing highest versus lowest SFA quintiles; the multivariate-adjusted odds ratio (OR) with 95% confidence interval (CI) was 1.64 (1.04-2.58) for global cognition and 1.65 (1.04-2.61) for verbal memory. By contrast, higher MUFA intake was related to better global cognitive (p for linear trend < 0.001) and verbal memory (p for linear trend = 0.009) trajectories, and lower OR (95% CI) of worst cognitive change in global cognition (0.52 [0.31-0.88]) and verbal memory (0.56 [0.34-0.94]). Total fat, PUFA, and trans-fat intakes were not associated with cognitive trajectory.
Interpretation: Higher SFA intake was associated with worse global cognitive and verbal memory trajectories, whereas higher MUFA intake was related to better trajectories. Thus, different consumption levels of the major specific fat types, rather than total fat intake itself, appeared to influence cognitive aging.
Copyright © 2012 American Neurological Association.
Conflict of interest statement
None of the authors report any potential financial or personal conflicts of interest pertaining to this manuscript.
Figures
Comment in
-
Cognition decline and saturated fat intake link questioned: confounders missed.Ann Neurol. 2012 Oct;72(4):626; author reply 626-7. doi: 10.1002/ana.23724. Ann Neurol. 2012. PMID: 23109158 No abstract available.
-
Good fats, bad fats, polyunsaturated fatty acids, and cognition in the elderly.Ann Neurol. 2013 Mar;73(3):438. doi: 10.1002/ana.23726. Epub 2012 Dec 7. Ann Neurol. 2013. PMID: 23225261 No abstract available.
Similar articles
-
Dietary fat intake and 6-year cognitive change in an older biracial community population.Neurology. 2004 May 11;62(9):1573-9. doi: 10.1212/01.wnl.0000123250.82849.b6. Neurology. 2004. PMID: 15136684
-
Monounsaturated, trans, and saturated Fatty acids and cognitive decline in women.J Am Geriatr Soc. 2011 May;59(5):837-43. doi: 10.1111/j.1532-5415.2011.03402.x. J Am Geriatr Soc. 2011. PMID: 21568955 Free PMC article.
-
Dietary fats and the APOE-e4 risk allele in relation to cognitive decline: a longitudinal investigation in a biracial population sample.J Nutr Health Aging. 2024 May;28(5):100211. doi: 10.1016/j.jnha.2024.100211. Epub 2024 Mar 19. J Nutr Health Aging. 2024. PMID: 38507884
-
Dietary fatty acids, age-related cognitive decline, and mild cognitive impairment.J Nutr Health Aging. 2008 Jun-Jul;12(6):382-6. doi: 10.1007/BF02982670. J Nutr Health Aging. 2008. PMID: 18548175 Review.
-
Total Dietary Fat Intake, Fat Quality, and Health Outcomes: A Scoping Review of Systematic Reviews of Prospective Studies.Ann Nutr Metab. 2021;77(1):4-15. doi: 10.1159/000515058. Epub 2021 Mar 31. Ann Nutr Metab. 2021. PMID: 33789278 Review.
Cited by
-
Effects of saturated and monounsaturated fatty acids on cognitive impairment: evidence from Mendelian randomization study.Eur J Clin Nutr. 2024 Jul;78(7):585-590. doi: 10.1038/s41430-024-01437-5. Epub 2024 Apr 17. Eur J Clin Nutr. 2024. PMID: 38632331
-
Association between erythrocyte membrane fatty acids and gut bacteria in obesity-related cognitive dysfunction.AMB Express. 2023 Dec 20;13(1):148. doi: 10.1186/s13568-023-01655-3. AMB Express. 2023. PMID: 38123761 Free PMC article.
-
Proposed solutions to anthropogenic climate change: A systematic literature review and a new way forward.Heliyon. 2023 Oct 10;9(10):e20544. doi: 10.1016/j.heliyon.2023.e20544. eCollection 2023 Oct. Heliyon. 2023. PMID: 37867892 Free PMC article.
-
Relationship between dietary macronutrients intake and biological aging: a cross-sectional analysis of NHANES data.Eur J Nutr. 2024 Feb;63(1):243-251. doi: 10.1007/s00394-023-03261-2. Epub 2023 Oct 16. Eur J Nutr. 2024. PMID: 37845359
-
Association between dairy intake and risk of incident dementia: the Ohsaki Cohort 2006 Study.Eur J Nutr. 2023 Oct;62(7):2751-2761. doi: 10.1007/s00394-023-03189-7. Epub 2023 Jun 19. Eur J Nutr. 2023. PMID: 37335358
References
-
- DeKosky ST, Marek K. Looking backward to move forward: early detection of neurodegenerative disorders. Science. 2003;302:830–834. - PubMed
-
- Lleo A, Greenberg SM, Growdon JH. Current pharmacotherapy for Alzheimer’s disease. Annu Rev Med. 2006;57:513–533. - PubMed
-
- Petersen RC, Thomas RG, Grundman M, et al. Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med. 2005;352:2379–2388. - PubMed
-
- Hu FB, Willett WC. Optimal diets for prevention of coronary heart disease. JAMA. 2002;288:2569–2578. - PubMed
-
- Harris WS. n-3 fatty acids and serum lipoproteins: human studies. Am J Clin Nutr. 1997;65:1645S–1654S. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- K08 AG029813-04/AG/NIA NIH HHS/United States
- CA047988/CA/NCI NIH HHS/United States
- R01 AG015933/AG/NIA NIH HHS/United States
- R01 HL080467-05/HL/NHLBI NIH HHS/United States
- R01 HL080467/HL/NHLBI NIH HHS/United States
- HL080467/HL/NHLBI NIH HHS/United States
- R01 CA047988-22/CA/NCI NIH HHS/United States
- R01 AG015933-09/AG/NIA NIH HHS/United States
- K08 AG029813/AG/NIA NIH HHS/United States
- R01 HL043851/HL/NHLBI NIH HHS/United States
- AG015933/AG/NIA NIH HHS/United States
- R01 CA047988/CA/NCI NIH HHS/United States
- R01 HL043851-10/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
